HopeStage
Back to all studies
TerminatedNCT00139074

Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients

Medication studyAges 18+DenmarkBipolarity
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Copenhagen and 6 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJuly 2005
Recruitment status
Terminated
Enrollment listed in the registry
17
Sponsor
AstraZeneca
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Denmark
Age range
Over 18 Years
Official registry ID
NCT00139074
Official title
Show the full official title

Phase IV Study to Investigate if Valproate Add-on Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients

Recruitment & locations

Terminated

Copenhagen · Esbjerg · Frederikssund

4 more locations
  • Haderslev
  • Hellerup
  • Kolding
  • Svendborg

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is AstraZeneca.

Does this study involve medication?

Yes. The study involves medication, including Quetiapine fumarate and sodium valproate.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies